The aim of this study is to determine the effect of 6 weeks supplementation of oleuropein on individuals diagnosed with metabolic syndrome. The baseline and end biochemical parameters and anthropometric measurements will be compared with control subjects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from Baseline in the Fasting Blood Glucose (mg/dl) at 6 weeks
Timeframe: 6 weeks
Change from Baseline in the Insulin (uU/mL) at 6 weeks
Timeframe: 6 weeks
Change from Baseline in the Triglyceride (TG) (mg/dl), high density lipoprotein (HDL-C) (mg/dl), low density lipoprotein (LDL-C) (mg/dl), Total Cholesterol (mg/dl) at 6 weeks
Timeframe: 6 weeks
Change from Baseline in the HOMA-IR at 6 weeks
Timeframe: 6 weeks
Change from Baseline in the BMI (kg/m2)
Timeframe: 6 weeks
Change from Baseline in the Anthropometric Measurements
Timeframe: 6 weeks